155177-92-7

Upstream product

• 136497-85-3 N-(9-fluorenylmethoxycarbonyl)-L-serine allyl ester 
• 155177-89-2 2-azido-4,6-O-benzylidene-2-deoxy-3-O-levulinoyl-β-D-galactopyranosyl fluoride 
• 155177-88-1 2-azido-4,6-O-benzylidene-2-deoxy-3-O-levulinoyl-α-D-galactopyranosyl fluoride 
• 147254-13-5 (tert-butyldimethyl)silyl 2-azido-4,6-O-benzylidene-2-deoxy-β-D-galactopyranoside 
• 40608-06-8 levulinic anhydride 

Downstream Products

• 155177-85-8 allyl N-(9-fluorenylmethoxycarbonyl)-[O-(2-azido-4,6-O-benzylidene-2-deoxy-α-D-galactopyranosyl)-(1[*]3)]-L-serine 

Relevant academic research and scientific papers

Stereoselective synthesis of a blood group A type glycopeptide present in human blood mucin

N,N-Dimethyl-O-(2-acetamido-2-deoxy-α-D-galactopyranosyl)-(1 → 3)-O-[( α-L-fucopyranosyl)-(1 → 2)]-O-( β-D-galactopyranosyl)-(1 → 3)-O-(2-acetamido-2-deoxy-α-D-galactopyranosyl)(1 → 3)-L-serine, a core 1 glycotetraosyl peptide structure and a predominant

Synthesis of a glycotetraosyl serine, a partial structure of an ovarian cyst mucin glycoprotein of blood group A activity

A glycotetraosyl serine containing blood group A determinant tetrasaccharide and its properly protected equivalent were synthesized in a regio- and stereocontrolled manner.